Telix Pharmaceuticals TLX
NASDAQ TLX
$11.34 -0.28 (-2.41%)
At close: Sep 29, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Convertible Debt (2023 - 2026)

Updated

Telix Pharmaceuticals' Convertible Debt was $520,000 in the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Convertible Debt (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Convertible Debt at Telix Pharmaceuticals came in at $562,000, down 7.6% from the prior year.

  • In earlier years, Convertible Debt was $608,180 in the year ended Dec 31, 2024 (+61.9%) and $375,622 in the year ended Dec 31, 2023.
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Convertible Debt since the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Telix Pharmaceuticals 3.94 Bn 2.88 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 520,000.00
Dec 31, 2025 562,000.00
Dec 31, 2024 608,179.64
Dec 31, 2023 375,621.51
API Access

Telix Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=TLX&period=max&api_key=YOUR_API_KEY